Select Medical reaffirmed earnings guidance for the year 2024. The company expects revenue to be in the range of $6.9 billion to $7.1 billion, fully diluted earnings per share to be in the range of $1.95 to $2.19.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.93 USD | -0.30% | -2.60% | +40.13% |
May. 06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
May. 06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.13% | 4.28B | |
+17.74% | 83.47B | |
-29.66% | 69.72B | |
-1.41% | 26.37B | |
+3.95% | 17.86B | |
-12.16% | 16.83B | |
+2.47% | 15.7B | |
+74.82% | 13.45B | |
+73.52% | 12.81B | |
-0.76% | 12.44B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Reaffirms Earnings Guidance for the Year 2024